Previous Close | 7.80 |
Open | 7.80 |
Bid | 4.10 |
Ask | 14.00 |
Strike | 150.00 |
Expire Date | 2026-01-16 |
Day's Range | 7.80 - 7.80 |
Contract Range | N/A |
Volume | |
Open Interest | 15 |
If Eli Lilly's (LLY) donanemab is approved by the FDA, it will become the second drug approved by the FDA to reduce the clinical decline associated with Alzheimer's disease.
Eli Lilly stock seesawed Tuesday after a Food and Drug Administration panel endorsed its Alzheimer's treatment, donanemab.
Is Eli Lilly stock a buy after a panel of advisors to the FDA unanimously backed its Alzheimer's drug? Is LLY stock a buy right now?